IL6 and acute respiratory distress syndrome: These MAbs may play a vital role in reducing IL6 level and reduce instances of ARDS in COVID-19 patients (Chan et al., 2013; Luo et al., 2020; Michot et al., 2020; Shaffer, 2020).